Seres Therapeutics soars on report of takeover offer

2025-09-08 09:04:34 ET

More on Seres Therapeutics

• Seres Therapeutics, Inc. 2025 Q2 - Results - Earnings Call Presentation
• Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript
• Seres?Therapeutics: Speculative Gem Backed By SER?155 FDA Breakthrough
• Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks
• Seres Therapeutics GAAP EPS of -$2.27 beats by $0.22

Read the full article on Seeking Alpha

For further details see: